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Abstract
Complement receptor-type 1 (CR1, CD35) is the immune-adherence receptor, a complement regulator, and an erythroid
receptor for Plasmodium falciparum during merozoite invasion and subsequent rosette formation involving parasitized and
non-infected erythrocytes. The non-uniform geographical distribution of Knops blood group CR1 alleles Sl1/2 and McCa/b
may result from selective pressures exerted by differential exposure to infectious hazards. Here, four variant short
recombinant versions of CR1 were produced and analyzed, focusing on complement control protein modules (CCPs) 15–25
of its ectodomain. These eleven modules encompass a region (CCPs 15–17) key to rosetting, opsonin recognition and
complement regulation, as well as the Knops blood group polymorphisms in CCPs 24–25. All four CR1 15–25 variants were
monomeric and had similar axial ratios. Modules 21 and 22, despite their double-length inter-modular linker, did not lie side-
by-side so as to stabilize a bent-back architecture that would facilitate cooperation between key functional modules and
Knops blood group antigens. Indeed, the four CR1 15–25 variants had virtually indistinguishable affinities for immobilized
complement fragments C3b (KD = 0.8–1.1 mM) and C4b (KD = 5.0–5.3 mM). They were all equally good co-factors for factor I-
catalysed cleavage of C3b and C4b, and they bound equally within a narrow affinity range, to immobilized C1q. No
differences between the variants were observed in assays for inhibition of erythrocyte invasion by P. falciparum or for
rosette disruption. Neither differences in complement-regulatory functionality, nor interactions with P. falciparum proteins
tested here, appear to have driven the non-uniform geographic distribution of these alleles.
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Introduction
The Swain-Langley (Sl1/2) and McCoy (McCa/b) Knops blood
group antithetical antigen pairs lie within the erythrocyte-borne
membrane glycoprotein, complement-receptor type 1 (CR1)
(CD35) [1,2]. Both the encoded amino acid sequence variations
occur in the vicinity of the 25th complement control protein (CCP)
module (or short consensus repeat) out of the 30 CCP modules
that constitute the ,1800-residue N-terminal ectodomain of the
most common size-variant of CR1 [3] (Fig. 1). The strikingly non-
uniform geographical distribution of these alleles has been much
discussed [4] [5]. Notably, both McCb (coding for E1590, McCa
codes for K1590) and Sl2 (coding for G1601, Sl1 codes for R1601)
are extremely rare in Caucasoids but common (prevalence of 45%
and 80%, respectively) in individuals of African descent [6]. Such
population differences probably arose due to selective pressure and
it was hypothesized that the Sl2 (and possibly McCb) alleles afford a
survival advantage in the context of a geographically localized
environmental hazard such as is posed by the malaria parasite
Plasmodium falciparum [4,5,7]. Malaria is probably responsible for
,1,100,000 deaths annually in Africa [8] but is largely absent
from Europe and North America.
Erythroid CR1 is a ligand used by P. falciparum merozoites for
sialic acid-independent invasion of red blood cells [9,10,11].
Moreover, CR1 on non-parasitized erythrocytes is a ligand for P.
falciparum erythrocyte membrane protein 1 (PfEMP1) borne on
infected erythrocytes; this interaction mediates formation of
‘‘rosettes’’, which consist of clusters of infected and non-infected
cells [12]. Rosette formation is associated with life-threatening
forms of cerebral malaria [13]. Correlation between CR1
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polymorphisms (Sl2/Sl2 vs. Sl1/Sl1) and resistance to severe
malaria was reported in a western Kenyan population [14], but
not in two studies of populations from The Gambia [15,16].
Selective-pressure hypotheses require that McC and Sl-encoded
variants diverge with respect to copy number expressed or to
structure-function relationships; but this has not been investigated
comprehensively. Complement receptor-type 1 [17] regulates
classical and alternative pathways of the complement system. It is
also the immune-adherence receptor, mediating transport by
erythrocytes of particles opsonised with complement-activation
specific fragments, C3b and C4b, to the primary lymphoid system
for clearance [18]. Modules 1–3 (site 1), 8–10 (site 2) and 15–17 (a
near-identical copy of site 2) are the first three modules of,
respectively, the first, second and third (out of four), highly similar
long-homologous repeats (A–D) accounting for the N-terminal 28
CCPs of the most common CR1 size variant (Fig. 1) [19]. These
sites interact with opsonic C3b and C4b [20] and, to a lesser
degree, the C3b breakdown product, iC3b, and are collectively
crucial to the immune-clearance role of CR1. They also accelerate
decay of C3 and C5 convertases, crucial multiple-subunit enzymes
in the complement cascade. Moreover, site 2 is a cofactor for
proteolytic cleavage of C3b and C4b [21,22,23,24] by factor I that
interrupts the complement cascade and generates ligands for other
complement receptors linking complement to cellular and
antibody-mediated immunity [25]. Importantly, site 1 also
mediates interactions with Rh4 [26] vital for sialic acid-
independent invasion by P. falciparum [11] while site 2 is a
candidate for interaction with PfEMP1 and rosette formation [27].
It is intriguing that the Knops blood group antigens in CCPs
24–25 do not occupy known functional sites of the CR1
ectodomain. Residues encoded by Sl1/2 and McCa/b lie within
long-homologous repeat D, seven modules away (in the primary
structure) from the nearest proven functional site (i.e. CCPs 15–17
or site 2 within long-homologous repeat C). Nonetheless, sites of
sequence variation could be spatially apposed to one or more
functional sites depending upon the overall architecture of CR1’s
long chain of CCPs [28,29,30,31]. In particular, the uniquely long
linking sequence of eight amino acid residues (compared to four
residues on average) connecting CCPs 21 and 22 (i.e. between
long-homologous repeats C and D, see Fig. 1) could represent a
molecular hinge, enabling the modules of long-homologous repeat
D to fold back onto long-homologous repeat C and hence
influence the activity of the second copy of site 2.
Thus the possibility requires investigation that sequence
variations in or near to CCP 25 influence C3b/C4b binding,
complement-regulatory activity or binding to Rh4 or PfEMP1,
despite being remote in the sequence from the primary sites of
interaction. It is also possible that long-homologous repeat D
possesses its own less well characterized or yet-to-be discovered
binding sites for host or parasite proteins. For example, classical
complement pathway protein C1q (part of the C1 complex that
also includes the serine protease C1r and C1s) reportedly binds
long-homologous repeat D of CR1 [32].
We prepared four eleven-CCP constructs, representing the McC
and Sl-encoded CR1 variants, along with a set of shorter
recombinant constructs encompassing modules at the border
between long-homologous repeats C and D (CCP 21–CCP 22).
We were thus able to show that Knops blood group variants in
long-homologous repeat D neither modulate structure nor
influence known functional activities of CR1 that might underlie
selective pressure.
Results
A panel of truncations were designed for this study and
produced in P. pastoris
We made truncations of CR1 (Fig. 2) in the same strain of Pichia
pastoris previously employed to produce biologically active full-
length factor H (FH) (a CR1 homologue containing 20 CCPs)
[33]. Recombinant CR1 15–25, i.e. CCPs 15–25, was designed as
the minimal CR1 fragment spanning the second copy of site 2
(CCPs 15–17) and variant residues 1601 (Sl1/2) in CCP 25 and
1590 (McCa/b) in the linker between CCPs 24 and 25.
Producing the four variants of this eleven-module fragment -
Glu1590/Gly1601 (EG, from McCb/Sl2), Lys1590/Arg1601 (KR, from
McCa/Sl1, .98% prevalence in Caucasoids), Lys1590/Gly1601
(KG, from McCa/Sl2) and Glu1590/Arg1601 (ER, from McCb/Sl1)
- in preference to an entire (e.g. 30-module) ectodomain of CR1,
allowed us to focus on a single functional site. Moreover, unlike in
the case of variants of CCPs 1–30, large amounts of material for
quantitative measurements and biophysical characterisation could
be produced. We also produced smaller fragments, CR1 21, CR1
21–22 and CR1 20–23 (Fig. 2), to investigate the potential of the
double-length linker between CCPs 21 and 22 to promote a bent-
back module chain, in which CCPs 24/25 lie close to CCPs 15–
17. All proteins were secreted in good yields and purified (Fig. 2)
using sequential ion-exchange and gel-filtration chromatographic
steps.
CCPs 21 and 22 of CR1 do not form a side-by-side
interaction
We compared 1H,15N-HSQC NMR spectra of CR1 21, CR1
21–22, and CR1 20–23 (Fig. 3). In these spectra each amide group
produces a cross peak the position of which is determined by its
15N (y-axis) and 1H (x-axis) chemical shifts. The spectra were of
high quality, featuring predominantly uniform line-widths and
excellent chemical shift dispersion, showing that these proteins are
properly folded. Nearly all cross peaks in the CR1 21 spectrum
overlap with cross peaks in the CR1 21–22 spectrum (Fig. 3A),
showing that attachment of CCP 22 to CCP 21 causes only minor
perturbations of chemical shifts for amide groups in CCP 21. This
implies that these modules share only a small inter-modular
Figure 1. Schematic of CR1. (A) Main cartoon shows the 30 CCPs
(ovals) in the ectodomain of the most common CR1 size-variant. Long-
homologous repeats (LHRs) and positions of functional sites (dark grey)
are indicated; the eight-residue linker between long-homologous
repeats C and D is drawn as a dotted line along with neighbouring
modules (grey); CCPs 24/25 wherein reside the Sl1/2 and McCa/b-
encoded antigens are also highlighted (thicker outline) and their
modeled 3D structures [43] drawn as cartoons with K1590 and R1601
side chains shown as spheres.
doi:10.1371/journal.pone.0034820.g001
Effect of Knops Antigens on CR1 Structure-Function
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interface consistent with an end-to-end (rather than side-by-side)
interaction. Likewise, many cross peaks in the partially assigned
spectrum of CR1 21–22 match to cross peaks in the spectrum of
CR1 20–23 (Figs. 3B,C); of those that do not, none corresponded
to residues in the linker between CCPs 21 and 22; in fact most lie
in module 22 (data not shown). These observations are consistent
with CCPs 21 and 22 retaining their end-to-end disposition within
the context of CR1 20–23.
To further investigate spatial arrangements of modules in CR1
20-23, samples were subjected to small-angle X-ray scattering
(SAXS) generating high-quality data with no concentration
dependency (Figs. 4A,B). The resulting DAMMIF ab initio model,
with an excluded volume of 59 nm3 - consistent with that expected
for a monomeric, properly folded, CR1 20–23 (29 Kd) - fitted well
to the SAXS profile (discrepancy, x=1.5) (Fig. 4A). Both the
model and the distance distribution, with a Dmax of 15 nm
(Fig. 4C), are fully consistent with a largely elongated arrangement
of the four modules (see insert in (Fig. 4A) and cannot be
reconciled with a stable bent-back conformation as was formed,
for example, by the six CCPs at the centre of FH that had a Dmax
of 10.4 nm [34].
Thus, in CR1 20–23, the long linker between CCPs 21 and 22
(i.e. between long-homologous repeats C and D) does not induce a
U-bend. Together with their immediate neighbours, these
modules form a highly elongated structure. Extrapolating to a
larger construct, CCPs 19 and 24 would be ,15 nm apart,
disfavouring apposition of CCPs 15–17 and CCPs 24–25. These
results suggest that sequence variations in CCPs 24–25 (of long-
homologous repeat D) have only local structural effects. To test
this, analytical ultracentrifugation (AUC) was used to compare
CR1 15–25 allotypic variants.
Biophysical analysis reveals no differences in gross
structures of variants
We subjected solutions of the CR1 15–25 allotypic variants to
AUC and compared their sedimentation coefficients and axial
ratios (Table 1). All had Svedberg values in the narrow range of
3.14–3.25, and calculated hydrodynamic radii in the range 5.55–
5.80 nm, with no indication of any loss of folded structure or self-
association over the concentration range (0.1–1 mg.ml21) mea-
sured. These results are in good agreement with estimates of
particles size distribution from dynamic light scattering (Fig. S1).
Their calculated axial ratios were also similar, within experimental
error, falling in the range of 5.6–6.6.
Thus, consistent with NMR and SAXS-derived structural
models of CCPs 20–23, the Knops blood group allotypic
variations in CCPs 24–25 do not induce structural differences in
CR1 15–25 detectable by AUC (or dynamic light scattering).
These data, taken together with the SAXS and NMR findings for
CR1 20–23, are best explained by an open architecture for CR1
15–25, in which contacts between non-adjacent modules are
improbable. On the other hand, the sequences of modules (CCPs
15–19 and CCPs 24–25) flanking the elongated section (CCPs 20–
23) cannot extend linearly and rigidly in opposite directions (since
that would have resulted in a structure with a much higher axial
ratio). It therefore remains conceivable that these flanking
sequences could cooperate in binding to a large ligand such as
C3b or C4b, even though in previous work no binding between
long-homologous repeat D (alone) and C3b/C4b was detected
[20]. This possibility, whereby long-homologous repeat D
contributes to binding C3b/C4b only after the higher affinity site
in long-homologous repeat C had been occupied, was explored
through binding assays.
All four CR1 15–25 variants bind equally well to opsonins
C3b and C4b
We investigated whether variant residues in CCPs 24–25
modulate the C3b/C4b-binding ability of CR1 functional site 2.
Experiments based on SPR (see Fig. 5, and Figs. S2, S3) provided
no evidence for such a proposition. All four CR1 15–25 variants
bind similarly well to immobilized C3b, with KD values in the
range of 0.8–1.1 mM, and to C4b, with KD values of 5.0–5.3 mM
(Table 2). These data may be compared to KD values for CR1 15–
17 of 1.1 mM (C3b) and 3.2 mM (C4b), measured on the same
C3b- and C4b-loaded flow cells of the CM5 sensor chip (Figs. S2,
S3). All the truncations bind less tightly to C3b and C4b than
sCR1 (measured on the same CM5 chip, KD= 0.53 mM for C3b
and KD= 0.91 mM for C4b; (Figs. S2, S3)); presumably this reflects
the avidity provided by the multiple sites present in the full-length
ectodomain. To provide independent validation of these results
that were based on studies of binding to covalently immobilized
(amine-coupled) C3b and C4b, an ELISA assay was conducted in
which C3b or C4b were adsorbed to polystyrene microtitre plates
(Fig. S4). These experiments also failed to distinguish between the
binding properties of CR1 15–25 variants. We concluded that the
variant residues of CCP 25 have neither direct nor indirect roles in
engagement of C3b and C4b by site 2.
Figure 2. Recombinant CR1 truncations produced for the
current study. The Coomassie-stained polyacrylamide gels show the
results of electrophoresis of successive fractions (with increasing elution
volumes, Ve) from size-exclusion chromatography for CR1-21, CR1 21–
22, CR1 20–23 and CR1 15–25 (the K1590,R1601 variant); reducing (R)
conditions in some lanes would reveal products of intra-modular
proteolytic ‘‘clipping’’ that would be held together by disulfide bonds
under non-reducing (NR) conditions.
doi:10.1371/journal.pone.0034820.g002
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Figure 3. CCPs 21–24 do not exhibit extensive inter-modular contacts. (A) 1H,15N heteronuclear single quantum coherence (HSQC) NMR
spectrum of CR1 21 overlaid on that of CR1 21–22. (B) An overlay of the HSQC spectra for CR1 21–22 and 20–23 with (C) blow-ups of two regions.
Cross-peaks are color-coded according to the CR1 fragment of origin, as indicated. A dearth of chemical shift changes for CCP 21 and CCP 21–22
amides following attachment of neighbouring modules suggests chemical shift-perturbing inter-modular contacts are limited.
doi:10.1371/journal.pone.0034820.g003
Figure 4. CCPs 21–24 do not exhibit extensive inter-modular contacts. (A) SAXS profile and fit of the DAMMIF ab initio model (red surface)
to the CR1 20–23 data (1.9 mg.ml21); (B) Guinier plot of the CR1 20–23 SAXS data at 1.9 mg.ml21 (open circles) and 3.3 mg.ml21 (open squares),
showing no significant concentration dependence of SAXS parameters (plots displaced on the vertical axis for clarity); (C) Distance distribution
function, p(r) for CR1 20–23.
doi:10.1371/journal.pone.0034820.g004
Effect of Knops Antigens on CR1 Structure-Function
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The CR1 15–25 variants have identical abilities to
regulate complement
Functional site 2 of CR1 is the predominant locus of cofactor
activity for factor I-catalyzed proteolysis of C3b and C4b (see
Figs. 6A,B). Cofactor activity very likely involves contacts between
CR1 and both C3b (or C4b) and factor I [35]. We showed (above)
that the long-homologous repeat C-copy of site 2 engages with
C3b and C4b independently of long-homologous repeat D.
Nonetheless it remained feasible that Knops blood group
variations in CCPs 24/25 influence recruitment, or activation
[35], of factor I to CR1:C3b or CR1:C4b complexes. We
conducted fluid-phase cofactor assays in which cleavage products
of CR1/factor I, acting on C3b or C4b. were detected in a
qualitative manner using SDS-PAGE, ensuring reactions had not
proceeded to completion. In all CR1 15–25 lanes and the sCR1
lane, the pattern and strengths of bands corresponding to cleavage
products (following a 60-minute incubation) appeared to be
identical in the case of C3b (Fig. 6C) and, likewise, in the case of
C4b (Fig. 6D). Thus all the recombinant variants had co-factor
activity for the cleavages made by factor I needed to generate
C3dg or C4d. No differences could be detected between the
variants in the amounts or nature of product generated.
The variants have equivalent affinities for C1q
Interaction of CR1 with C1q was reported previously, along
with suggestions that long-homologous repeat D (CCPs 22–28)
contributes to this binding event cases [32,36,37]. We measured
affinities of the four CR1 15–25 variants for C1q that had been
immobilized, via amine coupling, on the CM5 sensor chip surface
(under the same conditions and in the same series of experiments
used to obtain KD values for C3b and C4b) (Fig. 7A, Table 2).
Measured values lay in a narrow range of 5–6 mM, comparable
with a value of 8 mM for sCR1 (Fig. S5). CR1 1–3 (site 1) bound
weakly (KD.30 mM (not shown) but in this assay CR1 15–17 (site
2) bound better than sCR1 (KD,1 mM) while the nine-CCP
construct CR1 17–25 (i.e. missing CCPs 15 and 16) did not bind at
all (Fig. S5); these data suggesting that C1q binds to site 2 require
further verification. In any case, the results of SPR strongly
indicate that the McC and Sl-encoded variations had small or
negligible effects on binding of C1q. Very similar results were
obtained using an ELISA (see Fig. 7B) in which soluble C1q
binding to CR1 truncations adsorbed on a micro-titer plate was
measured.
PfRh4 invasion pathway
Erythroid CR1 is the receptor required for the major sialic acid-
independent route for invasion by multiple strains of P. falciparum
[9,10,11,26]. The key P. falciparum protein in this invasion
pathway, PfRh4, was previously shown to bind to CR1 CCPs 1–
3 (site 1), but not to the highly similar CCPs 15–17 (site 2) nor to
the Caucasoid variant (Lys1590/Arg1601) of CR1 15–25 that
includes CCPs 22–24; these modules are similar in sequence to
both CCPs 1–3 and CCPs 15–17 [26]. We examined the
previously unexplored possibility that PfRh4 engages with other,
non-Caucasoid, variants of CR1 15–25. According to SPR, none
of the CR1 15–25 variants (like CR1 15–17, CR1 24–25(KR) and
other negative controls) exhibited more than residual affinity for
an immobilized recombinant version of PfRh4 (PfRh4.9) corre-
sponding to its erythrocyte-binding N-terminal domain [38],
unlike the positive controls, CR1 1–3 and sCR1 (Fig. 8A). To
investigate whether the non-Caucasoid CR1 15–25 variants
nevertheless interfered with the PfRh4-CR1 invasion pathway,
their effects on parasite growth were monitored. As was observed
previously, invasion of both untreated and neuraminidase-treated
erythrocytes by 3D7 strain was inhibited by addition of sCR1,
whereas invasion of untreated erythrocytes by the parasite strain
W2mefDRh4, which lacks a functional CR1-PfRh4 pathway, was
unaffected by the presence of sCR1 (Fig. 8B) [26]. These results
served as a control for experiments with the CR1 15–25 variants
[9,11] (see Fig. 8B). In agreement with the SPR study, none of the
CR1 15–25 variants (unlike the positive control, sCR1) inhibited
invasion of nm-treated erythrocytes by P. falciparum. Thus the
Knops blood group antigens on CCPs 24/25 had no influence on
the susceptibility of erythrocytes to invasion by P. falciparum,
consistent with a location within the CR1 molecule that is remote
both in the sequence and in space from the key PfRh4-binding site
in CCPs 1–3 (site 1) [26].
All variants are equally implicated in P. falciparum
rosetting
Previous work implicated site 2 (CCPs 8–10 or CCPs 15–17) in
the rosette-mediating interaction between erythroid CR1 and
PfEMP1 expressed on the surface of infected erythrocytes [27].
We were unable (data not shown) to detect binding between any of
the CR1 truncations (including sCR1) and immobilized recombi-
nant versions of the N-terminal duffy binding-like domain from
PfEMP1 [39] (in the same set of SPR experiments used to measure
Table 1. AUC data for four CR1 15–25 variants.
Sample mg/ml s1 (S) s(20,w) [mean] (S) f/f0 SEDFIT f/f0 s, M Axial Ratio [mean] Rh (nm) [mean]
KR 0.5 3.13 3.25 [3.28] 2.10 2.06 5.64 [5.88] 5.75 [5.70]
0.25 3.19 3.31 1.85 2.03 6.11 5.65
EG 1 3.11 3.22 [3.25] 1.98 2.08 5.30 [5.63] 5.81 [5.75]
0.5 3.16 3.28 1.94 2.04 5.96 5.80
ER 0.5 3.22 3.33 [3.37] 1.81 2.01 6.40 [6.64] 5.61 [5.55]
0.25 3.22 3.34 2.02 2.01 6.40 5.60
0.125 3.32 3.44 1.39 1.95 7.14 5.44
KG 1 3.09 3.20 [3.26] 2.04 2.09 5.12 [5.67] 5.84 [5.74]
0.5 3.13 3.25 2.00 2.06 5.64 5.75
0.25 3.20 3.32 1.51 2.02 6.26 5.62
1Symbols in this table: s= sedimentation coefficient (in Svedbergs); f/fo= frictional ratio from SEDFIT and from the combination of s and molecular mass (M);
Rh=hydrodynamic radius; KR, etc. refer to CR1 15–25 (KR), etc.
doi:10.1371/journal.pone.0034820.t001
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the affinity of sCR1 for Rh4.9). Nonetheless, we were able to
elaborate on previous findings by confirming that not only was
rosetting inhibited by sCR1 and by CR1 15–25, but it was also
ameliorated by CR1 15–17 (as shown previously) and even by
CR1 17 alone (Fig. 9A). This appeared to be a module-specific
effect since rosetting was not inhibited by CR1 21, CR1 21–22 or
CR1 20–23 (Fig. 9B), nor by full-length factor H or several factor
H fragments (Fig. 9C). Importantly, we could not detect any
difference between the four variants of CR1 15–25 in terms of
their ability to disrupt rosetting (Fig. 9B).
Discussion
Complement receptor-type 1, a rare example of a protein whose
ectodomain is composed entirely from modules of the same type, is
a product of gene duplication and exon shuffling [40]. This
evolutionary heritage is particularly apparent amongst CR1 size-
variants (190–280 kDa), which possess different numbers of
homologous blocks of seven CCPs arranged in long-homologous
repeats [19]. In the 30-CCP ectodomain of the most common
(gene frequency of ,0.85) size-variant, four tandem N-terminal
long-homologous repeats (A–D), are followed by two membrane-
proximal CCPs. Each CCP contains about 60 amino acid residues
organized in a b-strand-rich compact unit stabilized by pairs of
disulfides between invariant cysteines (Cys I-Cys III, Cys II-Cys
IV) [41,42]. We investigated structural and functional conse-
quences of Knops blood group antigenic variations of CR1 likely
to be under geographical region-specific selective pressure
resulting in non-uniform distribution of allotypes among global
populations. These involve loss or gain of charge through
substitution of residues predicted to be surface-exposed (see
Fig. 1) and thus the E1590/G1601 (McCb/Sl2, common in sub-
Saharan African) and K1590/R1601 (McCa/Sl1, predominant in
Caucasoids) [2] variants will differ significantly in the electrostatic
surfaces presented by their CCPs 24–25 regions (in long-
homologous repeat D, Fig. 1) [43].
Linkers of just four amino acid residues join long-homologous
repeats A and B, and long-homologous repeats B and C, but an
eight-residue linker connects the last residue of long-homologous
repeat C (i.e. consensus Cys IV of CCP 21) to the first of long-
homologous repeat D (i.e. consensus Cys I of CCP 22). We looked
for, but found no evidence of, structural or functional interactions
between long-homologous repeats D and C despite the potential
for this double-length linker between long-homologous repeats to
allow or promote a close-to-180-degree bend in the molecule.
Indeed, our results suggest the modules flanking this linker adopt
an extended arrangement consistent with a stalk-like or spacer role
for long-homologous repeat D, helping to project the functional
sites-bearing CCPs 1–21 away from the membrane and clear of
the glycocalyx of erythrocytes, where over 85% of human CR1
resides [2]. Thus, we infer that single or double-residue
substitutions in long-homologous repeat D of surface-exposed
residues are unlikely to have structural or electrostatic conse-
quences for long-homologous repeats A–C.
Our SPR and ELISA-derived binding data are fully consistent
with a large body of previous work suggesting N-terminal modules
of long-homologous repeats A–C cooperate in interacting with the
activated products of C3 and C4 (C3b and C4b) and their
complexes, while long-homologous repeat D (the location of variant
residues 1590 and 1601) does not engage directly with these ligands
[17,20,21,23,24]. Long-homologous repeats A, B and C each carry
an N-terminal set of three modules that presumably bind to surface-
tethered C3b/C4b in a manner similar to one another and to factor
H-modules 1–3 (i.e. the long axes of modules aligned with the long
axis of C3b and with the N-terminal of the three modules distal to
the surface) [44]. Thus it is easy to envisage long-homologous
repeats A–C, borne on the long-homologous repeat D stalk,
adopting an architecture that has a quasi-three-fold axis of
symmetry. Our results indicated that CCPs 15–25 encompass
binding sites for C1q, which is multi-subunit activator of the classical
pathway. Our studies suggested CCPs 15–17 make a major
contribution to C1q binding whereas previous studies ascribed
more importance to long-homologous repeat-D [32,36,37]; in our
studies CCPs 26–28 of long-homologous repeat D were absent so
we did not make a direct comparison between these two possibilities.
Consistently with our structural findings, we demonstrated that Sl
and McC-encoded sequence variations within long-homologous
repeat-D appear to have no effect on a range of CR1 properties
resident in long-homologous repeats A–C including: C3b-binding
and C4b-binding, vital for the long-recognized key biological role of
human CR1 as the immune adherence receptor [45]; cofactor
activity for factor I, needed for protection of erythrocyte surfaces from
Figure 5. CR1 15–25 variants bind equally well to C3b and C4b. Representative SPR-derived binding curves for the CR1 15–25 variants (as
indicated in parentheses) flowed over C3b (upper four panels) or C4b (lower four panels) that were amine-coupled to CM5 chips (see also Figs. S1 and
S2). In each case, a set of sensorgrams recorded for a range of CR1 15–25 concentrations (0.25 mM, 0.5 mM, 1 mM, 2.5 mM, 5 mM, 10 mM), are shown
above the plot of response versus [CR1 15–25] used to calculate (see Methods) the KD value listed in Table 2. CR1 variants that are widespread
amongst Caucasoids (KR) or Africans (EG) bind equally both to C3b and C4b.
doi:10.1371/journal.pone.0034820.g005
Table 2. Tabulated data derived from SPR experiments.
CR1 fragment C3b KD (mM) [Rmax]
1 C4b KD (mM) [Rmax] C1q KD (mM) [Rmax ]
CR1 15–17 1.0660.02 [14961] 3.2060.07 [9461] 0.8260.02 [51.460.3]
CR1 1–3 3862 [12863] 11.260.2 [13361] 30.960.9 [9461]
CR1 15–25(KR) 0.9960.01 [26961] 5.160.1 [16962] 5.760.3 [6262]
CR1 15–25(ER) 1.0960.01 [29161] 5.360.1 [17062] 5.760.3 [6162]
CR1 15–25(KG) 1.0560.01 [27961] 5.260.1 [16262] 5.560.3 [5462]
CR1 15–25(EG) 0.8060.01 [29561] 5.060.1 [15262] 5.160.3 [4762]
sCR1 0.5360.01 [16961] 0.9160.01 [12161] 861 [3963]
1Rmax = fitted maximum response, expressed in response units.
doi:10.1371/journal.pone.0034820.t002
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C3b proliferation and its potentially cytolytic consequences [46];
interactions with P. falciparum-derived erythrocyte-borne PfEMP1,
required for rosetting [12,27]; and engagement by the P. falciparum
adhesin PfRh4 for P. falciparum invasion of erythrocytes [11]. Our
results additionally demonstrated that binding to CR1 of C1q occurs
entirely independently of the Sl and McC-encoded variations.
For rosette-disruption assays we chose parasite clone R29, on
the grounds that it is the best-characterized CR1-sensitive P.
falciparum rosetting strain [12,27]. In previous work, no differences
were observed between strains in response to various agents such
as the CR1 mAb J3B11 and recombinant CR1 15–17 [27]; on this
basis it was decided not to initiate extensive testing of other strains
for rosette disruption. Although our experiments were not
conducted on variant versions of the full-length ectodomain, this
is unlikely to have eroded their relevance in respect of the assays
performed in this study. Interactions between long-homologous
repeat D and long-homologous repeats A or B, but not C, would
require an unfeasibly contorted architecture for the CR1 molecule.
It also seems unlikely that CCPs 26–30 (absent in our truncation)
are a requirement for a putative interaction between long-
homologous repeats D and C. On the other hand, our focus on
soluble truncations as opposed to membrane-bound variants does
leave open a number of untested possibilities. In particular,
although we observed no differences in self-associative properties
of CR1 15–25, it is possible that a stalk-like long-homologous
repeat D is important for mediating the clustering of CR1
molecules [47]. The relevance of CR1 clustering to merozoite
invasion or rosetting has not been investigated but it has been
reported to be important for cell deformability, motility of cells in
microvasculature and hence the immune clearance role of CR1. It
is also possible that Sl and McC-encoded sequence variations affect
a putative interaction, of unknown physiological significance, with
mannan binding lectin [37]. Moreover, CR1 is displayed on other
cell-types than erythrocytes and may have other functions than
those tested in this study. Finally, we used C4b from pooled
plasma and therefore we did not take account of polymorphic
variation in C4 that also exhibits a non-uniform distribuion across
geographical regions of origin.
African-derived populations are characterized by a slightly
higher (0.12 versus 0.18) incidence of a larger size-variant of CR1
[1], and high copy numbers of CR1 on erythrocytes [48] as well as
increased frequency of the Sl2 and McCb alleles [3]. The current
study makes a correlation between the last of these sources of
polymorphic variation and malaria seem less likely. Nor does the
data support hypotheses based on differential abilities amongst
these Knops blood group antigenic variants to protect erythrocytes
against cytolytic complement attack. Our C3b- and C4b-binding
data suggest that all the variants will be equally good at clearing
immune complexes, although our studies of soluble fragments did
not take into account the possible roles in this respect of CR1
clustering. Overall, a likely scenario is that the source of selective
pressure on these variants in long-homologous repeat D arises
from less-well understood interactions between CR1 and patho-
genic organisms. For example, elevated frequencies of McCb and
Sl2 alleles have been correlated to resistance to Mycobacterium
tuberculosis infections [49].
Materials and Methods
Protein production
Recombinant versions of truncated CR1 (the Caucasian, i.e.
Lys1590, Arg1601, variant) were produced in a Pichia pastoris
Figure 6. All four CR1 15–25 variants have similar cofactor activity. The products of CR1/Factor I action on (A) C3b and (B) C4b. In the
schematics, disulfides linkages (S-S) are shown as solid lines, and suspected non-disulfide covalent-linkage artifacts (thought to originate from
dimerisation in the C4b samples) shown as dotted lines. The gels show the results of SDS-PAGE performed on biotinylated C3b (C) or C4b (D) (see
Methods) following incubation (for one hour) with factor I and the CR1 15–25 variant indicated below (KR, KE etc.). A positive control is provided by
soluble CR1 (sCR1); negative controls are either bovine serum albumin (BSA) or minus factor I (-FI). Notes: the 2008-Da C3f runs off the gel; the C4b c
chain stains poorly; in the initial C4b sample, degradation products at 25 kDa and 67 kDa are present as contaminants; the reaction was deliberately
stopped prior to completion to allow a comparison to be made between the variants. See Figure S3 for ELISA results.
doi:10.1371/journal.pone.0034820.g006
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expression host using methods described previously. In brief, DNA
coding for CCPs 21 (E1317-R1392), CCPs 21–22 (E1317-S1456),
CCPs 20–23 (S1257-I1516) or CCPs 15–25 (T940-S1647) (num-
bering refers to unprocessed initial gene product) was PCR-
amplified from CR1 cDNA then ligated into the TOPO plasmid
vector (Invitrogen) that was used to transform Top10 E. coli cells
(Invitrogen). Amplified and subsequently extracted (using the
QIAprep Miniprep Kit, Qiagen) DNA was digested with PstI and
XbaI and the insert was ligated into the pPICZ aB vector
(Invitrogen) downstream of the DNA for the Saccharomyces cerevisiae
a-mating factor secretion signal. Plasmids were amplified in E. coli
cells, linearised and used to transform P. pastoris KM71H cells for
production of protein that is directed into the secretory pathway.
Purification from media after cell removal was achieved by cation-
exchange chromatography followed by a second ion-exchange
chromatography step and gel-filtration chromatography. Proteins
exhibiting N-linked glycosylation were treated after the first
purification step with the endoglycosidase Endo Hf (New England
Biolabs). Purification was monitored by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) performed under
both reducing and non-reducing conditions. All of the recombinant
truncations of CR1 carried the expression artifact EAEAAG at their
N-termini. For isotopic enrichment, cells were grown in minimal
media supplemented with 15N-ammonium sulfate and (for double
labeling) 13C-glucose (during growth phase) and 13C-methanol
(during induction phase). A 15N,2H-labelled sample of CR1 20–23
was produced by supplementing buffered minimal glycerol with 15N
ammonium sulfate and also replacing H2O with 98% v/v D2O.
Starting with DNA for CR1 15–25(KR), the QuikChange Kit
(Stratagene) along with the appropriate oligonucleotides was used
Figure 7. Affinities for C1q. (A) Representative SPR-derived binding curves for CR1 15–25 variants flowed over a CM5 chip loaded (via amine
coupling) with C1q (see also Fig. S4). Upper: sensorgrams recorded for a range of CR1 15–25 concentrations (as in Fig. 3). Lower: plots of response
versus [CR1 15–25] used to calculate (see Methods) the KD values listed in Table 2. CR1 variants that are widespread amongst Caucasoids (KR) or
Africans (EG) bind equally to C1q. (B) Data obtained by ELISA showing that C1q (140 ng.mL21, average of three experiments) bound equally to each
of the four variants of CR1 15–25 (adhered to the micro-titer plate). In these experiments, sCR1 was used as a positive control. Error bars represent
standard errors of the mean.
doi:10.1371/journal.pone.0034820.g007
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to introduce the nucleotide substitutions needed to encode the
Knops blood group antigenic variations (i.e. single substitutions
K1590E and R1601G and double substitution K1590E/R1601G).
NMR spectroscopy
All NMR data were collected in 5-mm NMR tubes on an
Avance800 NMR spectrometer (Bruker) fitted with a cryoprobe,
processed using TOPSPIN (Bruker), then analyzed by utilizing the
ANALYSIS module of the common computing protocol for NMR
(CCPNMR) software package [50]. Two-dimensional 15N-1H
HSQC spectra and three-dimensional triple-resonance spectra
(CACBNH and CACB(CO)NH) [51] were acquired at 37uC on a
300 mM sample of the 13C,15N-labelled CR1 21–22 protein in
20 mM deuterated sodium acetate, pH 4.5, containing 10% v/v
D2O and 0.02% w/v NaN3. Two-dimensional
15N-1H HSQC
and TROSY spectra were collected on 233 mM 15N-labelled CR1
21 and 2 mM 15N-labelled CR1 21–22 samples, respectively,
under the same conditions. Partial backbone and 13Cb resonance
assignments were determined for CR1 21–22 according to
standard procedures.
Analytical Ultracentrifugation
Sedimentation velocity analysis (at 1860.5uC) was performed
on 0.4-ml protein samples (0.2–0.4 mg.ml21 in PBS, pH 7.5), on a
XL-A analytical ultracentrifuge (Beckman). A series of radial scans
of optical density (279 nm) across the centrifuge cell was collected
(Proteome Lab software, Beckman-Coulter). An initial scan was
performed immediately upon attaining the set rotor speed
(45,000 rpm); 80 subsequent scans were recorded at two-minute
intervals. Each resulting data set was analyzed (SEDFIT [52])
yielding values of the s-distribution parameter c(s) as a function of
sedimentation coefficient (s). For non-linear fitting of optical
density values versus radial distance in SEDFIT, the resolution was
set to 150, and a confidence factor set to 0.68. An average value
Figure 8. None of CR1 15–25 variants interact with P. falciparum protein Rh4. (A) In an SPR experiment, no CR1 15–25 variant had significant
affinity for immobilized Rh4.9, unlike positive controls sCR1 and CR1 1–3 (26). Other constructs lacking CCPs 1–3 (CR1 10–11, CR1 15–17, CR1 20–23,
CR1 21–22 and CR1 24–25(KR)) were likewise lacking in affinity for Rh4.9 and, like BSA, served as negative controls. (B) The PfRh4 invasion pathway
was not inhibited in the presence of CR1 15–25 variants. Parasite strains 3D7 (black bars for untreated, white bars for nm-treated erythrocytes) and
W2mefDRh4 (grey bars, untreated erythrocytes) were tested in growth assays in the presence of final concentrations of 0.5 mg/ml of the four CR1 15–
25 variants (KR, ER etc.). Growth (% of control) on the y-axis refers to the % parasitemia in the presence of CR1 constructs relative to the % parasitemia
with the addition of PBS (arbitrarily set to be 100%).
doi:10.1371/journal.pone.0034820.g008
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for the frictional ratio (F) was determined over a series of fits and
used as a default for all fittings; baseline, meniscus, and cell base
radial positions were floated. The final profile, stored as a
continuous distribution, was analyzed within the general software
set for data analysis, ‘‘pro Fit’’ (QuantumSoft, Zurich). The
maximal value of the c(s) function was used to define the
sedimentation coefficient of the target molecule. A value of the
partial specific volume (0.72160.001 ml.g21 for all four allotypic
variants) was computed (using SEDNTERP [53]), which was also
employed to compute density and viscosity properties of the buffer
solution, enabling correction of raw s values to standard conditions
of solvent viscosity and density (s20,w). The diffusion coefficient (an
inverse function of F) of each species was estimated in the
conventional manner from s, M and partial specific volume within
a locally written utility for hydrodynamic calculations, Biomols 2.
From each of the F values determined it was straightforward to
compute (using SEDNTERP), on the basis of an assumed ‘typical’
(for protein) value of solvation (1.4, vol/vol), an estimate for the
overall ‘shape’ of the solute particle, modeled as a prolate ellipsoid
of revolution.
Small-angle X-ray scattering (SAXS)
Synchrotron radiation X-ray scattering data were collected on
the633 beam line of the EMBL (DESY, Hamburg) [54,55], using
a MAR345 image plate detector (MarResearch, Norderstedt,
Germany) and 120-s exposure times. Solutions of CR1 20–23 (1.9
and 3.3 mg.ml21) were measured (10uC) in 50 mM potassium
phosphate (KP) buffer, pH 7.4. The sample-to-detector distance
(2.7 m) covered a range of momentum transfer 0.1,s,6.0 nm21.
No radiation damage was observed during a second 120-s
exposure. Data from the detector were normalized to the
transmitted beam intensity, averaged and the scattering of buffer
solutions subtracted. Difference curves were scaled for solute
concentration. Data manipulations were performed using PRI-
MUS [56]. Forward scattering I(0) and radius of gyration (Rg) were
determined from Guinier analysis [57], assuming that at very small
Figure 9. CR1 15–25 variants do not differ in ability to disrupt P. falciparum rosetting. (A) Both CR1 10–11 (identical to CR1 17–18) and
single-module CR1 17 can disrupt rosetting of P. falciparum clone IT/R29, as can anti-CR1 antibody (J3B11) and CR1 15–17 [27] used here as positive
controls. The truncation mutants corresponding to CCPs 20–23 (B) and the CR1 homologue, factor H (FH, full-length or fragments as indicated below)
(C) did not disrupt rosetting, and served as negative controls. (D) A comparison of the four CR1 15–25 variants suggested they were all equally as
effective as full-length sCR1 and CR1 15–17 in terms of rosette disruption. KP: 50 mM potassium phosphate buffer; The mean and standard error of at
least four experiments for each graph are shown. *** p,0.001 by ANOVA and Tukey’s multiple comparison test.
doi:10.1371/journal.pone.0034820.g009
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angles (s,1.3/Rg), intensity, I(s), = I(0)exp(-(sRg)
2/3). These
parameters were also estimated from the full scattering curves
using the indirect Fourier transform method implemented in
GNOM [58], along with the distance-distribution function p(r) and
maximum particle dimensions Dmax. Molecular weight was
estimated by comparing extrapolated forward scattering with that
of a reference solution of bovine serum albumin. Due to
uncertainty in MWt estimation resulting from uncertainty in
measured protein concentrations, an excluded volume of solutes
was determined from the ab initio modeling program DAMMIF
[59]. For globular proteins, this hydrated particle volume in nm3 is
approximately 1.5 to 2 times the MWt in kDa. Low-resolution
shape envelopes for CR1 constructs were determined by ab initio
bead-modeling in DAMMIF [59]. The results of multiple
DAMMIF reconstructions were aligned using SUPCOMB [60]
to determine the most representative model from each of the ab
initio methods. Averaged DAMMIF models were also determined
using DAMAVER [56] and then adjusted, so that they agree with
the experimentally determined excluded volume, using DAM-
FILT [61].
Surface plasmon resonance (SPR)
Duplicate SPR experiments were carried out (25uC) on a
Biacore T100 (GE Healthcare). C3b, C4b and C1q (Complement
Technology, Texas) were immobilized using standard amine
coupling, and dissociation constants measured as described [62].
Briefly, 1620 response units (RUs), 1518 RUs and 2125 RUs of
C3b, C4b and C1q, respectively, were immobilized on three of
four flow cells of a Biacore Series S carboxymethylated dextran
(CM5) sensor chip. Experiments were performed by flowing over
the chip 30 ml.minute21 analyte solution containing a range of
concentrations of CR1 fragments that had been dialyzed into
10 mM Hepes-buffered 150 mM saline with 3 mM EDTA and
0.05% v/v polysorbate 20 (HBS-EP; pH 7.4). Regeneration was
achieved by flowing 1.0 M NaCl over chip surfaces. Dissociation
constants (KDs) were calculated (using Biacore T100 evaluation
software v. 2.0) by fitting steady-state binding levels derived from
background-subtracted traces to a one-to-one stoichiometry
steady-state model. For blank subtractions, a reference surface
was prepared by performing two consecutive dummy amine-
coupling reactions in the absence of any proteins.
Parasite culture and growth inhibition assays
P. falciparum asexual stages were maintained in human O+
erythrocytes in RPMI-HEPES medium with 50 mg.ml21 hypo-
xanthine, 25 mM NaHCO3, 20 mg.ml
21 gentamicin, and 0.5%
w/v Albumax II (Gibco; Invitrogen) in 1% O2, 4% CO, and 95%
N2 at 37uC and synchronized by standard methods. 3D7 is a
cloned line derived from NF54 obtained from David Walliker,
Edinburgh University. W2mef is a cloned line derived from
Indochina III/CDC strain. W2mefDRh4 was derived from
W2mef by genetic disruption of the PfRh4 gene as described
[63] Growth inhibition assays (GIA) were performed as described,
with the following modifications [64]. Neuraminidase (66.7 mU/
ml)-treated or normal erythrocytes in culture medium were
inoculated with late-trophozoite stage parasites to give a
parasitemia of 1% and hematocrit of 1% in a volume of 50 ml.
CR1 fragments or PBS were added at the beginning of the assay.
Growth assays were performed in 96-well round-bottom microtiter
plates (Becton Dickinson) over one cycle of parasite growth. After
48 hours, the parasitemia was determined by flow cytometry of
ethidium bromide-stained trophozoite-stage parasites using a
FACSCalibur (BD Biosciences) and a plate reader. For each well
40,000 cells or more were counted. Growth was expressed as mean
parasitemia obtained from triplicate readings. At least two to four
independent assays were performed, each in triplicate. Growth (%
of control) refers to the % parasitemia in the presence of CR1
constructs relative to the % parasitemia with the addition of PBS
(arbitrarily set to be 100%).
Rosetting assays
P. falciparum parasites (clone IT/R29) were cultured and selected
for rosetting as described previously [39,65]. The red cells in
which the parasites are grown for the rosetting experiments were
all group O and different donors were used for different replicate
experiments. The red cells were used for parasite culture up to 10
days after drawing. Our unpublished data show that donor red
cells form rosettes well up to 10 days, but rosetting starts to reduce
after that time. For rosette-disruption assays, parasite cultures were
pre-stained with 25 mg.ml21 ethidium bromide then washed once
and re-suspended at 2% hematocrit in bicarbonate-free RPMI
(Sigma) containing 25 mM Hepes and 10% v/v normal human
serum. Aliquots (25–50 ml) of pre-stained culture suspension in
micro-centrifuge tubes were mixed with soluble recombinant CR1
proteins in KP buffer to give a final concentration of 20 mM.
Mixtures were incubated at 37uC for 30 minutes. During this
incubation period, cells were re-suspended at ten-minute intervals
by agitation. Subsequently a drop (,10 ml) of the pre-stained
culture suspension was placed on a slide on a slide underneath a
22622-mm cover slip and viewed with a fluorescence microscope.
Infected erythrocytes (that fluoresce orange due to parasite DNA)
could be discriminated from non-infected cells. A total of 200
infected red blood cells were counted and scored as either being in
a rosette, or not, where a rosette is defined as ‘‘an infected cell with
two or more uninfected red cells sticking to it’’. Only mature (that
is, pigmented trophozoite or schizont) infected cells were counted.
This allowed calculation of ‘‘rosette frequency’’ as the number of
infected cells in rosettes expressed as a percentage of the total
number of infected cells counted. The rosette frequency in the
presence of recombinant CR1 fragments was compared to that of
negative controls with no added protein (an equivalent volume of
PBS or RPMI binding medium or KP buffer was added instead of
protein). Positive controls showed the rosette disruption obtained
by 0.1 mg.ml21 of a monoclonal antibody to CR1 site 2 (J3B11) or
20 mM CR1 15–17 [27]. Rosette frequencies were compared by
ANOVA using Graphpad Prism software (La Jolla, USA).
Complement assays
To estimate ability of CCP 15–25 variants to act as cofactors for
C3b cleavage by factor I, 7.5 ml biotinylated C3b (3.3 mg.ml21, i.e.
25 pg), 2.5 ml factor I (from Complement Technology)
(1.6 mg.ml21, i.e. 4 pg) and 10 ml CCP 15–25 (1 mg.ml21 i.e.
10 pg), or 10 ml sCR1 (a gift from Henry Marsh, Celdex
Pharmaceuticals) (2.7 mg.ml21 i.e. 27 pg), were mixed in a final
reaction volume of 30 ml of 25 mM phosphate buffer, pH 7.3,
containing 50 mM NaCl. For C4b cleavage assays, 7.5 ml
biotinylated C4b (5 mg.ml21, 37.5 pg), 2.5 ml factor I
(1.6 mg.ml21, 4 pg) and 10 ml CCP 15–25 5 mg.ml21, 50 pg) or
10 ml sCR1 (13.5 mg.ml21, 135 pg), were incubated in a final
volume of 30 ml of 25 mM phosphate buffer, with 50 mM NaCl.
Incubations (one hour, 37uC) were initiated by addition of factor I
and stopped by addition of 10 ml of 46 NuPAGE (Invitrogen)
reducing loading buffer followed by heating (95uC) for four
minutes. Then 18-ml aliquots were loaded onto 4–12% w/v
acrylamide NuPAGE gels (one for C3b cleavages, another for C4b
cleavages). Protein bands were transferred to nitrocellulose in a
Bio-Rad semi-dry apparatus, blocked overnight in 5% w/v dried
milk powder (Lab Scientific) and stained with avidin-horse radish
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peroxidase (Pierce). Amersham ECL+ reagent was used to develop
the blot. C3b and C4b were purchased from Complement
Technology and biotinylated using Sulfo-NHS-LC biotin (Pierce).
The bands representing cleavage products of the C3b or C4b a’
chains were compared by eye.
ELISAs
For these experiments, C3b and C4b were purchased from
Complement Technology (Tyler, Texas). To C3b-coated or C4b-
coated micro-titer plates, solutions of 1 mg.ml21 sCR1 or CR1
15–25 variants (in 25 mM NaCl) were added. The primary
antibody used for detection was rabbit anti-CR1, and the
secondary antibody was a goat anti-rabbit IgG conjugated with
horseradish peroxidase. Results of three separate experiments
were averaged. For comparisons of C1q binding, sCR1 or CR1
15–25 variants were coated on micro-titer plates. Solutions of C1q
(140 ng.ml21 in 75 mM NaCl) (results of three experiments
averaged) were added. The primary antibody was rabbit anti-C1q
and secondary antibodiy anti-rabbit IgG conjugated with HRP.
Supporting Information
Figure S1 Particle size distribution according to dy-
namic light scattering. Shown are overlays of dynamic light
scattering-derived particle size profiles for the indicated recombi-
nant CR1 fragments (see key). Data were collected using a
Zetasizer Nano S system (Malvern Instruments Ltd., UK) on
samples of ,3.5 mg.ml21 protein in phosphate-buffered saline at
25uC.
(TIFF)
Figure S2 Binding of CR1 constructs to C3b by SPR.
Sensorgrams (left) (for a concentration series, see Methods in main
text) and response (response units (RU)) versus concentration (M)
plots (right) for, from top to bottom, CR1 15–17 (site 2), CR1 1–3 (site
1), CR1 15–25 (ER), CR1 15–25 (KG) and sCR1. The fitted (see
Methods in main text) KD values (shown in mM 6 error, where the
error applies to last significant figure shown, e.g. for CR1 15–17,
KD= 1.0660.01 mM) are displayed in the plots but also summa-
rized in Table 2, main text.
(TIFF)
Figure S3 Binding of CR1 constructs to C4b by SPR. As
for Figure S2 except C4b replaced C3b.
(TIFF)
Figure S4 Binding of CR1 constructs to C3b and C4b by
ELISA. There are no significant differences between the CR1 15–
25 variants in terms of their ability to bind to C3b and C4b
according to an ELISA (see Methods in main text).
(TIFF)
Figure S5 Binding of CR1 constructs to C1q by SPR. As
for Figure S2 except C1q replaced C3b.
(TIFF)
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